Consumers are now almost as likely to say they learn about new medications from advertisements on linear or connected TV as ...

Illustrating its confidence in its proprietary products, the Southern California company has announced an ambitious plan to ...

Fittingly enough, for its third acquisition in as many years, Deerfield Group has picked up Triple Threat Communications. | ...

Real Chemistry has made a flurry of leadership appointments, including hiring JJ Schmuckler from VML to fill a newly created role while also making changes at 21Grams and its communications group.

GSK has been enjoying regulatory momentum in recent months as it works to bring its antibody-drug conjugate (ADC) Blenrep ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Under the transaction, Perrigo is handing over several popular skincare franchises, including ACO, Biodermal, Emolium and Iwostin. Perrigo acquired the latter two Eastern European brands, plus the non ...

GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

For the second time this year, Leo Pharma has struck a partnership with a major drugmaker, this time paying Boehringer ...

The use of SGLT2 inhibitors has been a game-changer in the treatment of heart failure (HF). Now, another drug class has ...